Preferred Label : Myasthenic syndrome, congenital, 1b, fast-channel;
Symbol : CMS1B;
CISMeF acronym : CMS1B;
Type : Phenotype, molecular basis known;
Description : Congenital myasthenic syndromes are genetic disorders of the neuromuscular junction
that can be classified by the site of the transmission defect: presynaptic, synaptic,
and postsynaptic. FCCMS is an autosomal recessive form of postsynaptic CMS. For a
discussion of genetic heterogeneity of CMS, see 608931. In most cases, FCCMS is caused
by recessive gain-of-function mutations that decrease activity of the AChR by slowing
the rate of opening of the receptor channel, speeding the rate of closure of the channel,
or decreasing the number of openings of the channel during ACh occupancy. The result
is failure to achieve threshold depolarization of the endplate and consequent failure
to fire an action potential. FCCMS is the physiologic opposite of slow-channel CMS
(SCCMS; 601462), but the 2 disorders cause similar phenotypes. Sine et al. (2003)
provided a detailed analysis of the mechanistic diversity underlying fast-channel
congenital CMS. Autosomal dominant inheritance has rarely been described.;
Inheritance : Autosomal dominant; Autosomal recessive;
Molecular basis : Caused by mutations in the cholinergic receptor, nicotinic, alpha polypeptide-1 gene
(CHRNA1, 100690.0007);
Prefixed ID : #608930;
Origin ID : 608930;
UMLS CUI : C4225405;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
Validated automatic mappings to NTBT